OGSIVEO

Drug SpringWorks Therapeutics, Inc.
Total Payments
$493,656
Transactions
4,065
Doctors
2,254
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $493,656 4,065 2,254

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $301,242 125 61.0%
Food and Beverage $109,537 3,662 22.2%
Travel and Lodging $42,442 263 8.6%
Consulting Fee $40,435 15 8.2%

Top Doctors Receiving Payments for OGSIVEO — Page 91

Doctor Specialty Location Total Records
Jasdeep Sidhu Student in an Organized Health Care Education/Training Program Louisville, KY $13.16 1
, M.D Surgery Dakota Dunes, SD $13.16 1
, M.D Radiation Oncology Indianapolis, IN $13.16 1
, M.D., PH.D Radiation Oncology Beaumont, TX $13.14 1
, M.D., PH.D Pediatric Hematology-Oncology Pittsburgh, PA $10.77 1

About OGSIVEO

OGSIVEO is a drug associated with $493,656 in payments to 2,254 healthcare providers, recorded across 4,065 transactions in the CMS Open Payments database. The primary manufacturer is SpringWorks Therapeutics, Inc..

Payment data is available from 2024 to 2024. In 2024, $493,656 was paid across 4,065 transactions to 2,254 doctors.

The most common payment nature for OGSIVEO is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($301,242, 61.0% of total).